Pilot studies of superfractionated radiotherapy and combination chemotherapy in limited oat cell carcinoma of the bronchus
Journal Article
·
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
There are sound radiobiologic and suggestive clinical rationale for superfractionating the radiotherapeutic regimens employed for the therapy of rapidly growing malignancies. Oat cell carcinoma of the bronchus is such a tumor. The authors report their experience combining aggressive systemic combination chemotherapy with supperfractionated radiotherapy for the treatment of limited oat cell carcinoma of the bronchus. Overall, patient tolerance was satisfactory and a complete remission rate of 74% was achieved. It remains to be proven, in a prospective randomized fashion, whether this approach is superior to current conventional management.
- Research Organization:
- Univ. of Manitoba, Winnipeg, MB (Canada)
- OSTI ID:
- 6268459
- Journal Information:
- Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 10:10
- Country of Publication:
- United States
- Language:
- English
Similar Records
''Total'' therapy for oat cell carcinoma of the lung
Randomized comparison of radiotherapy with a radiotherapy-chemotherapy combination in Stage IV carcinoma of the head and neck. [/sup 60/Co]
Clinical trial of razoxane and radiotherapy for inoperable carcinoma of the bronchus
Journal Article
·
Sat Jan 01 00:00:00 EST 1977
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:6268459
Randomized comparison of radiotherapy with a radiotherapy-chemotherapy combination in Stage IV carcinoma of the head and neck. [/sup 60/Co]
Conference
·
Fri May 01 00:00:00 EDT 1981
· Cancer; (United States)
·
OSTI ID:6268459
+4 more
Clinical trial of razoxane and radiotherapy for inoperable carcinoma of the bronchus
Conference
·
Sat Sep 01 00:00:00 EDT 1979
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:6268459
+1 more
Related Subjects
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
62 RADIOLOGY AND NUCLEAR MEDICINE
BRONCHI
BIOLOGICAL RADIATION EFFECTS
FIBROSIS
RADIOINDUCTION
IMMUNOSUPPRESSION
RADIOTHERAPY
SIDE EFFECTS
CARCINOMAS
CHEMOTHERAPY
COBALT 60
ENDOXAN
FRACTIONATED IRRADIATION
GAMMA RADIATION
NITROSOUREAS
ONCOVIN
PATIENTS
X RADIATION
ALKALOIDS
ALKYLATING AGENTS
ANTIMITOTIC DRUGS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOLOGICAL EFFECTS
COBALT ISOTOPES
DISEASES
DRUGS
ELECTROMAGNETIC RADIATION
IMMUNOSUPPRESSIVE DRUGS
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
IONIZING RADIATIONS
IRRADIATION
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
MEDICINE
MINUTES LIVING RADIOISOTOPES
NEOPLASMS
NITROSO COMPOUNDS
NUCLEAR MEDICINE
NUCLEI
ODD-ODD NUCLEI
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
PATHOLOGICAL CHANGES
RADIATION EFFECTS
RADIATIONS
RADIOISOTOPES
RADIOLOGY
RESPIRATORY SYSTEM
THERAPY
YEARS LIVING RADIOISOTOPES
560151* - Radiation Effects on Animals- Man
550603 - Medicine- External Radiation in Therapy- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
BRONCHI
BIOLOGICAL RADIATION EFFECTS
FIBROSIS
RADIOINDUCTION
IMMUNOSUPPRESSION
RADIOTHERAPY
SIDE EFFECTS
CARCINOMAS
CHEMOTHERAPY
COBALT 60
ENDOXAN
FRACTIONATED IRRADIATION
GAMMA RADIATION
NITROSOUREAS
ONCOVIN
PATIENTS
X RADIATION
ALKALOIDS
ALKYLATING AGENTS
ANTIMITOTIC DRUGS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOLOGICAL EFFECTS
COBALT ISOTOPES
DISEASES
DRUGS
ELECTROMAGNETIC RADIATION
IMMUNOSUPPRESSIVE DRUGS
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
IONIZING RADIATIONS
IRRADIATION
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
MEDICINE
MINUTES LIVING RADIOISOTOPES
NEOPLASMS
NITROSO COMPOUNDS
NUCLEAR MEDICINE
NUCLEI
ODD-ODD NUCLEI
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
PATHOLOGICAL CHANGES
RADIATION EFFECTS
RADIATIONS
RADIOISOTOPES
RADIOLOGY
RESPIRATORY SYSTEM
THERAPY
YEARS LIVING RADIOISOTOPES
560151* - Radiation Effects on Animals- Man
550603 - Medicine- External Radiation in Therapy- (1980-)